

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular basement membrane development (GO:0032836) | 5.65020335 |
| 2 | skeletal muscle adaptation (GO:0043501) | 4.94575181 |
| 3 | muscle filament sliding (GO:0030049) | 4.92386601 |
| 4 | actin-myosin filament sliding (GO:0033275) | 4.92386601 |
| 5 | regulation of activation of Janus kinase activity (GO:0010533) | 4.91485059 |
| 6 | carnitine shuttle (GO:0006853) | 4.88033951 |
| 7 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.82374355 |
| 8 | negative regulation of mast cell activation (GO:0033004) | 4.77750693 |
| 9 | lysine catabolic process (GO:0006554) | 4.74121002 |
| 10 | lysine metabolic process (GO:0006553) | 4.74121002 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 4.63246767 |
| 12 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 4.63135935 |
| 13 | negative regulation of phagocytosis (GO:0050765) | 4.58028831 |
| 14 | regulation of sequestering of triglyceride (GO:0010889) | 4.52638757 |
| 15 | 2-oxoglutarate metabolic process (GO:0006103) | 4.31593574 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 4.21399318 |
| 17 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.19651115 |
| 18 | actin-mediated cell contraction (GO:0070252) | 4.04271537 |
| 19 | creatine metabolic process (GO:0006600) | 4.01468653 |
| 20 | peptidyl-proline hydroxylation (GO:0019511) | 3.99836741 |
| 21 | response to inactivity (GO:0014854) | 3.99654812 |
| 22 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.97817785 |
| 23 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.96304462 |
| 24 | valine metabolic process (GO:0006573) | 3.96231747 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.92401201 |
| 26 | glycine metabolic process (GO:0006544) | 3.85352310 |
| 27 | pre-miRNA processing (GO:0031054) | 3.80762162 |
| 28 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.80717004 |
| 29 | protein hydroxylation (GO:0018126) | 3.80185887 |
| 30 | regulation of fatty acid oxidation (GO:0046320) | 3.77903696 |
| 31 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.76008851 |
| 32 | NADH metabolic process (GO:0006734) | 3.73880270 |
| 33 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.73204976 |
| 34 | carnitine transmembrane transport (GO:1902603) | 3.72060647 |
| 35 | positive regulation of fatty acid oxidation (GO:0046321) | 3.64001449 |
| 36 | fatty acid beta-oxidation (GO:0006635) | 3.63557137 |
| 37 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.62853151 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 3.58780944 |
| 39 | muscle cell fate commitment (GO:0042693) | 3.57252736 |
| 40 | biotin metabolic process (GO:0006768) | 3.57148668 |
| 41 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.55339665 |
| 42 | cellular response to epinephrine stimulus (GO:0071872) | 3.54901425 |
| 43 | peripheral nervous system axon ensheathment (GO:0032292) | 3.54280241 |
| 44 | myelination in peripheral nervous system (GO:0022011) | 3.54280241 |
| 45 | positive regulation of adherens junction organization (GO:1903393) | 3.52276076 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 3.50948466 |
| 47 | amino-acid betaine transport (GO:0015838) | 3.47307932 |
| 48 | carnitine transport (GO:0015879) | 3.47307932 |
| 49 | tricarboxylic acid metabolic process (GO:0072350) | 3.46220653 |
| 50 | skeletal muscle contraction (GO:0003009) | 3.44679302 |
| 51 | fatty acid homeostasis (GO:0055089) | 3.42246637 |
| 52 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.37489863 |
| 53 | negative regulation of stress fiber assembly (GO:0051497) | 3.37489327 |
| 54 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.36020197 |
| 55 | striated muscle hypertrophy (GO:0014897) | 3.34192350 |
| 56 | actin filament-based movement (GO:0030048) | 3.33478070 |
| 57 | fatty acid oxidation (GO:0019395) | 3.28615552 |
| 58 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.28394193 |
| 59 | carnitine metabolic process (GO:0009437) | 3.26713578 |
| 60 | striated muscle contraction (GO:0006941) | 3.22030338 |
| 61 | low-density lipoprotein particle clearance (GO:0034383) | 3.21811349 |
| 62 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.19879135 |
| 63 | myofibril assembly (GO:0030239) | 3.19699111 |
| 64 | lipid oxidation (GO:0034440) | 3.19083132 |
| 65 | aspartate family amino acid catabolic process (GO:0009068) | 3.18134178 |
| 66 | acetyl-CoA metabolic process (GO:0006084) | 3.17151168 |
| 67 | oxaloacetate metabolic process (GO:0006107) | 3.17088246 |
| 68 | response to epinephrine (GO:0071871) | 3.17037230 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.15940792 |
| 70 | negative regulation of cell size (GO:0045792) | 3.15152164 |
| 71 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.14674896 |
| 72 | proline transport (GO:0015824) | 3.14463594 |
| 73 | formation of translation preinitiation complex (GO:0001731) | 3.12526511 |
| 74 | regulation of early endosome to late endosome transport (GO:2000641) | 3.10992513 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 3.08249866 |
| 76 | regulation of coenzyme metabolic process (GO:0051196) | 3.06187093 |
| 77 | regulation of cofactor metabolic process (GO:0051193) | 3.06187093 |
| 78 | succinate metabolic process (GO:0006105) | 3.06130413 |
| 79 | regulation of cholesterol homeostasis (GO:2000188) | 3.04160559 |
| 80 | regulation of translational fidelity (GO:0006450) | 3.01414663 |
| 81 | camera-type eye morphogenesis (GO:0048593) | 3.01382588 |
| 82 | cardiac muscle contraction (GO:0060048) | 3.00627053 |
| 83 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.00118047 |
| 84 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98980031 |
| 85 | folic acid metabolic process (GO:0046655) | 2.97247580 |
| 86 | protein localization to kinetochore (GO:0034501) | 2.96263402 |
| 87 | fatty acid catabolic process (GO:0009062) | 2.95351953 |
| 88 | regulation of translational termination (GO:0006449) | 2.95141160 |
| 89 | regulation of cholesterol storage (GO:0010885) | 2.94058250 |
| 90 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.93778333 |
| 91 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.92429797 |
| 92 | short-chain fatty acid metabolic process (GO:0046459) | 2.91720607 |
| 93 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.90988846 |
| 94 | triglyceride catabolic process (GO:0019433) | 2.90752914 |
| 95 | embryonic camera-type eye development (GO:0031076) | 2.89879845 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 2.89268827 |
| 97 | serine family amino acid metabolic process (GO:0009069) | 2.89020918 |
| 98 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.87903431 |
| 99 | muscle hypertrophy (GO:0014896) | 2.87554936 |
| 100 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86803862 |
| 101 | actomyosin structure organization (GO:0031032) | 2.86068188 |
| 102 | 4-hydroxyproline metabolic process (GO:0019471) | 2.86026625 |
| 103 | sarcomere organization (GO:0045214) | 2.84416312 |
| 104 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.83087952 |
| 105 | positive regulation of cell junction assembly (GO:1901890) | 2.82672124 |
| 106 | positive regulation of focal adhesion assembly (GO:0051894) | 2.82672124 |
| 107 | COPI coating of Golgi vesicle (GO:0048205) | 2.82464925 |
| 108 | Golgi transport vesicle coating (GO:0048200) | 2.82464925 |
| 109 | glycogen biosynthetic process (GO:0005978) | 2.82358961 |
| 110 | glucan biosynthetic process (GO:0009250) | 2.82358961 |
| 111 | regulation of execution phase of apoptosis (GO:1900117) | 2.82322810 |
| 112 | regulation of spindle organization (GO:0090224) | 2.82225873 |
| 113 | mitochondrial DNA metabolic process (GO:0032042) | 2.80888100 |
| 114 | positive regulation of lipid storage (GO:0010884) | 2.79907614 |
| 115 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.79816982 |
| 116 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.78983357 |
| 117 | positive regulation of histone deacetylation (GO:0031065) | 2.76428336 |
| 118 | response to hepatocyte growth factor (GO:0035728) | 2.76153555 |
| 119 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.76153555 |
| 120 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.75877717 |
| 121 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.75638602 |
| 122 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.75491370 |
| 123 | mitotic nuclear envelope disassembly (GO:0007077) | 2.74743605 |
| 124 | lipid particle organization (GO:0034389) | 2.73236844 |
| 125 | cardiac myofibril assembly (GO:0055003) | 2.72586152 |
| 126 | branched-chain amino acid metabolic process (GO:0009081) | 2.72268368 |
| 127 | acylglycerol catabolic process (GO:0046464) | 2.71630845 |
| 128 | neutral lipid catabolic process (GO:0046461) | 2.71630845 |
| 129 | plasma membrane repair (GO:0001778) | 2.70412129 |
| 130 | membrane raft organization (GO:0031579) | 2.70145855 |
| 131 | nuclear pore organization (GO:0006999) | 2.69724627 |
| 132 | cysteine metabolic process (GO:0006534) | 2.69649019 |
| 133 | maternal placenta development (GO:0001893) | 2.67705049 |
| 134 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.66949576 |
| 135 | regulation of relaxation of muscle (GO:1901077) | 2.66742536 |
| 136 | branched-chain amino acid catabolic process (GO:0009083) | 2.66407501 |
| 137 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.65562461 |
| 138 | regulation of mitotic spindle organization (GO:0060236) | 2.65506008 |
| 139 | protein localization to chromosome, centromeric region (GO:0071459) | 2.65376316 |
| 140 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.65193070 |
| 141 | import into cell (GO:0098657) | 2.64889254 |
| 142 | peptidyl-lysine dimethylation (GO:0018027) | 2.64848829 |
| 143 | striated muscle adaptation (GO:0014888) | 2.64365177 |
| 144 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.63884835 |
| 145 | protein localization to cell surface (GO:0034394) | 2.62951035 |
| 146 | nuclear envelope disassembly (GO:0051081) | 2.62778885 |
| 147 | membrane disassembly (GO:0030397) | 2.62778885 |
| 148 | regulation of fatty acid metabolic process (GO:0019217) | 2.62660027 |
| 149 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.62531554 |
| 150 | intracellular lipid transport (GO:0032365) | 2.62372385 |
| 151 | DNA unwinding involved in DNA replication (GO:0006268) | 2.61675617 |
| 152 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.60720892 |
| 153 | mitotic metaphase plate congression (GO:0007080) | 2.60532785 |
| 154 | mitotic chromosome condensation (GO:0007076) | 2.59917102 |
| 155 | macroautophagy (GO:0016236) | 2.58658643 |
| 156 | maturation of 5.8S rRNA (GO:0000460) | 2.58518426 |
| 157 | response to mercury ion (GO:0046689) | 2.56422056 |
| 158 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.54623584 |
| 159 | monocarboxylic acid catabolic process (GO:0072329) | 2.53508899 |
| 160 | one-carbon metabolic process (GO:0006730) | 2.52749060 |
| 161 | quaternary ammonium group transport (GO:0015697) | 2.52562472 |
| 162 | regulation of sulfur metabolic process (GO:0042762) | 2.52382224 |
| 163 | serine family amino acid biosynthetic process (GO:0009070) | 2.52378333 |
| 164 | keratan sulfate catabolic process (GO:0042340) | 2.52136227 |
| 165 | cellular response to prostaglandin stimulus (GO:0071379) | 2.51489508 |
| 166 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.51025846 |
| 167 | acylglycerol homeostasis (GO:0055090) | 2.50967731 |
| 168 | triglyceride homeostasis (GO:0070328) | 2.50967731 |
| 169 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.49927411 |
| 170 | tetrapyrrole biosynthetic process (GO:0033014) | 2.49871629 |
| 171 | pentose-phosphate shunt (GO:0006098) | 2.49423036 |
| 172 | skeletal muscle fiber development (GO:0048741) | 2.48896572 |
| 173 | kynurenine metabolic process (GO:0070189) | 2.48593877 |
| 174 | positive regulation of Rap GTPase activity (GO:0032854) | 2.47906044 |
| 175 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 2.47629766 |
| 176 | linoleic acid metabolic process (GO:0043651) | 2.47161579 |
| 177 | response to muscle activity (GO:0014850) | 2.43134787 |
| 178 | growth hormone receptor signaling pathway (GO:0060396) | 2.42699828 |
| 179 | cellular response to growth hormone stimulus (GO:0071378) | 2.37376300 |
| 180 | primary alcohol catabolic process (GO:0034310) | 2.37198955 |
| 181 | glycolytic process (GO:0006096) | 2.36504749 |
| 182 | muscle contraction (GO:0006936) | 2.35129711 |
| 183 | induction of positive chemotaxis (GO:0050930) | 2.32880772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.41732736 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.08595981 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.50669975 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.16028042 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.58188901 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.96415694 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.95469153 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90173797 |
| 9 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.89205483 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.73715165 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72637477 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.70545050 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66762718 |
| 14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.65594210 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.58210538 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.51721424 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.46476483 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40941726 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.33577657 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.29847683 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.24133397 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22243287 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.20022210 |
| 24 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.18585936 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17171871 |
| 26 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.11926813 |
| 27 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.11926813 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.11459322 |
| 29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09102882 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07768728 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.04037003 |
| 32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.99932072 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.98040145 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97357016 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96080177 |
| 36 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.94967515 |
| 37 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.91125533 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86974937 |
| 39 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.74999099 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.74253503 |
| 41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73455347 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.70391717 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55181235 |
| 44 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54041661 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.53433040 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52622761 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.50756837 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50284157 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.49854428 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49655103 |
| 51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.48913106 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44120340 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43287132 |
| 54 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.43266077 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.43211610 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43071816 |
| 57 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.42712206 |
| 58 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.40295504 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.38686416 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38657615 |
| 61 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38622912 |
| 62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38109916 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.37188595 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37110364 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36942527 |
| 66 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.35482837 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.35284388 |
| 68 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35115495 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34499086 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32579790 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32056295 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31478147 |
| 73 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31373729 |
| 74 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29871136 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29075288 |
| 76 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28617757 |
| 77 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26836977 |
| 78 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.26501382 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26486825 |
| 80 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25322201 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22960758 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22312225 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22275780 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.21254082 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20016077 |
| 86 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18698999 |
| 87 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.17726209 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16952757 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16852862 |
| 90 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14343243 |
| 91 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14241989 |
| 92 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.13653403 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13255692 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12705090 |
| 95 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.12699882 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12566149 |
| 97 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11663568 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11309774 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10930886 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10772287 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10757063 |
| 102 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10738866 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10164140 |
| 104 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08290099 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07514987 |
| 106 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.07464398 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06861290 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06643548 |
| 109 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06432704 |
| 110 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06374052 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05951343 |
| 112 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05765279 |
| 113 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05452575 |
| 114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05362786 |
| 115 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03850186 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03798893 |
| 117 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02346919 |
| 118 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02346919 |
| 119 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02341479 |
| 120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01444088 |
| 121 | MAF_26560356_Chip-Seq_TH1_Human | 1.01265781 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01241829 |
| 123 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01224062 |
| 124 | P68_20966046_ChIP-Seq_HELA_Human | 1.00881031 |
| 125 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00800085 |
| 126 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99163259 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99160260 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99150874 |
| 129 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99113741 |
| 130 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98992884 |
| 131 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98365876 |
| 132 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98198294 |
| 133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97539797 |
| 134 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97384883 |
| 135 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96481163 |
| 136 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95602269 |
| 137 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95207069 |
| 138 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95100522 |
| 139 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94656294 |
| 140 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94509199 |
| 141 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92032112 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91651036 |
| 143 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91106980 |
| 144 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90827773 |
| 145 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90617938 |
| 146 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90601149 |
| 147 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89638565 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89326981 |
| 149 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89255357 |
| 150 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88126663 |
| 151 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87530475 |
| 152 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86743243 |
| 153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86454320 |
| 154 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86037749 |
| 155 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85487037 |
| 156 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85481273 |
| 157 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.85293114 |
| 158 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85086199 |
| 159 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84869086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.35355331 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.23141306 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.09188125 |
| 4 | MP0005257_abnormal_intraocular_pressure | 3.04548260 |
| 5 | MP0002332_abnormal_exercise_endurance | 3.00178992 |
| 6 | MP0005670_abnormal_white_adipose | 2.99830478 |
| 7 | MP0003646_muscle_fatigue | 2.99228484 |
| 8 | MP0004130_abnormal_muscle_cell | 2.96711447 |
| 9 | MP0005451_abnormal_body_composition | 2.78788862 |
| 10 | MP0005666_abnormal_adipose_tissue | 2.67399769 |
| 11 | MP0005365_abnormal_bile_salt | 2.65752159 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.57844687 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.53836170 |
| 14 | MP0005360_urolithiasis | 2.38295924 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.34513757 |
| 16 | MP0004272_abnormal_basement_membrane | 2.34486855 |
| 17 | MP0005377_hearing/vestibular/ear_phenot | 2.16570979 |
| 18 | MP0003878_abnormal_ear_physiology | 2.16570979 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.11923650 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.01056437 |
| 21 | MP0003111_abnormal_nucleus_morphology | 1.98870238 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.89679120 |
| 23 | MP0009840_abnormal_foam_cell | 1.88371225 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.85147682 |
| 25 | MP0004087_abnormal_muscle_fiber | 1.80811999 |
| 26 | MP0005375_adipose_tissue_phenotype | 1.76935929 |
| 27 | MP0005083_abnormal_biliary_tract | 1.76400481 |
| 28 | MP0002269_muscular_atrophy | 1.75723828 |
| 29 | MP0005330_cardiomyopathy | 1.75096977 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.70534952 |
| 31 | MP0005248_abnormal_Harderian_gland | 1.67449087 |
| 32 | MP0010630_abnormal_cardiac_muscle | 1.66408563 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.66252555 |
| 34 | MP0002102_abnormal_ear_morphology | 1.64293054 |
| 35 | MP0010307_abnormal_tumor_latency | 1.63086761 |
| 36 | MP0000749_muscle_degeneration | 1.62097874 |
| 37 | MP0003252_abnormal_bile_duct | 1.61920104 |
| 38 | MP0000751_myopathy | 1.60655400 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.58594565 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.58287313 |
| 41 | MP0005503_abnormal_tendon_morphology | 1.57658325 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.54393165 |
| 43 | MP0003693_abnormal_embryo_hatching | 1.52563105 |
| 44 | MP0000609_abnormal_liver_physiology | 1.52252855 |
| 45 | MP0002971_abnormal_brown_adipose | 1.51673270 |
| 46 | MP0010094_abnormal_chromosome_stability | 1.50881339 |
| 47 | MP0000747_muscle_weakness | 1.50451412 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.49463038 |
| 49 | MP0003077_abnormal_cell_cycle | 1.48801334 |
| 50 | MP0001730_embryonic_growth_arrest | 1.47090110 |
| 51 | MP0009672_abnormal_birth_weight | 1.45294479 |
| 52 | MP0003984_embryonic_growth_retardation | 1.44596832 |
| 53 | MP0002088_abnormal_embryonic_growth/wei | 1.43042693 |
| 54 | MP0005275_abnormal_skin_tensile | 1.42243436 |
| 55 | MP0001672_abnormal_embryogenesis/_devel | 1.41042913 |
| 56 | MP0005380_embryogenesis_phenotype | 1.41042913 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.40084699 |
| 58 | MP0003091_abnormal_cell_migration | 1.39188451 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.38971795 |
| 60 | MP0004147_increased_porphyrin_level | 1.37551171 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.37125833 |
| 62 | MP0003567_abnormal_fetal_cardiomyocyte | 1.34885233 |
| 63 | MP0004957_abnormal_blastocyst_morpholog | 1.33142769 |
| 64 | MP0004233_abnormal_muscle_weight | 1.30121741 |
| 65 | MP0001544_abnormal_cardiovascular_syste | 1.27972504 |
| 66 | MP0005385_cardiovascular_system_phenoty | 1.27972504 |
| 67 | MP0008775_abnormal_heart_ventricle | 1.27739863 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.25995701 |
| 69 | MP0004197_abnormal_fetal_growth/weight/ | 1.25258486 |
| 70 | MP0002108_abnormal_muscle_morphology | 1.24908936 |
| 71 | MP0003045_fibrosis | 1.24751962 |
| 72 | MP0000733_abnormal_muscle_development | 1.22643565 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.21672193 |
| 74 | MP0005266_abnormal_metabolism | 1.21214704 |
| 75 | MP0009780_abnormal_chondrocyte_physiolo | 1.21194576 |
| 76 | MP0002106_abnormal_muscle_physiology | 1.18622837 |
| 77 | MP0003329_amyloid_beta_deposits | 1.18367503 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.17851532 |
| 79 | MP0006138_congestive_heart_failure | 1.17420957 |
| 80 | MP0000013_abnormal_adipose_tissue | 1.16835412 |
| 81 | MP0001697_abnormal_embryo_size | 1.16703896 |
| 82 | MP0005058_abnormal_lysosome_morphology | 1.14998054 |
| 83 | MP0005165_increased_susceptibility_to | 1.14970257 |
| 84 | MP0009115_abnormal_fat_cell | 1.14687124 |
| 85 | MP0008961_abnormal_basal_metabolism | 1.14626585 |
| 86 | MP0002132_abnormal_respiratory_system | 1.14471525 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 1.13278536 |
| 88 | MP0000003_abnormal_adipose_tissue | 1.12441849 |
| 89 | MP0002086_abnormal_extraembryonic_tissu | 1.12197812 |
| 90 | MP0001348_abnormal_lacrimal_gland | 1.11945463 |
| 91 | MP0000350_abnormal_cell_proliferation | 1.11086851 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 1.09711772 |
| 93 | MP0002970_abnormal_white_adipose | 1.09654952 |
| 94 | MP0003566_abnormal_cell_adhesion | 1.09394096 |
| 95 | MP0005620_abnormal_muscle_contractility | 1.09307069 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 1.09219003 |
| 97 | MP0002972_abnormal_cardiac_muscle | 1.05339790 |
| 98 | MP0004484_altered_response_of | 1.04745969 |
| 99 | MP0000343_altered_response_to | 1.03494937 |
| 100 | MP0002080_prenatal_lethality | 1.03016866 |
| 101 | MP0002909_abnormal_adrenal_gland | 1.01755816 |
| 102 | MP0005334_abnormal_fat_pad | 0.97659963 |
| 103 | MP0000266_abnormal_heart_morphology | 0.97627136 |
| 104 | MP0010030_abnormal_orbit_morphology | 0.95798213 |
| 105 | MP0000598_abnormal_liver_morphology | 0.95396169 |
| 106 | MP0001849_ear_inflammation | 0.95279974 |
| 107 | MP0005332_abnormal_amino_acid | 0.94911203 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.93772121 |
| 109 | MP0002084_abnormal_developmental_patter | 0.93027102 |
| 110 | MP0002295_abnormal_pulmonary_circulatio | 0.91448871 |
| 111 | MP0009053_abnormal_anal_canal | 0.91405860 |
| 112 | MP0000604_amyloidosis | 0.90362766 |
| 113 | MP0003186_abnormal_redox_activity | 0.88966819 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.88907945 |
| 115 | MP0002085_abnormal_embryonic_tissue | 0.88612611 |
| 116 | MP0002697_abnormal_eye_size | 0.88261477 |
| 117 | MP0003959_abnormal_lean_body | 0.87938947 |
| 118 | MP0009278_abnormal_bone_marrow | 0.87481061 |
| 119 | MP0005171_absent_coat_pigmentation | 0.87073661 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.86077782 |
| 121 | MP0005369_muscle_phenotype | 0.85587447 |
| 122 | MP0003828_pulmonary_edema | 0.84830542 |
| 123 | MP0009703_decreased_birth_body | 0.83785194 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.82798253 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.82798253 |
| 126 | MP0005187_abnormal_penis_morphology | 0.82693189 |
| 127 | MP0002060_abnormal_skin_morphology | 0.82205505 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.81520324 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.81442671 |
| 130 | MP0003123_paternal_imprinting | 0.80028124 |
| 131 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79617655 |
| 132 | MP0008007_abnormal_cellular_replicative | 0.79209633 |
| 133 | MP0000569_abnormal_digit_pigmentation | 0.77912335 |
| 134 | MP0001958_emphysema | 0.77224362 |
| 135 | MP0002078_abnormal_glucose_homeostasis | 0.77165420 |
| 136 | MP0010234_abnormal_vibrissa_follicle | 0.75540989 |
| 137 | MP0001915_intracranial_hemorrhage | 0.74979136 |
| 138 | MP0005193_abnormal_anterior_eye | 0.74059437 |
| 139 | MP0001661_extended_life_span | 0.73704493 |
| 140 | MP0004808_abnormal_hematopoietic_stem | 0.71965655 |
| 141 | MP0002234_abnormal_pharynx_morphology | 0.70458127 |
| 142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69824725 |
| 143 | MP0004085_abnormal_heartbeat | 0.68929182 |
| 144 | MP0006082_CNS_inflammation | 0.68389603 |
| 145 | MP0001666_abnormal_nutrient_absorption | 0.68079073 |
| 146 | MP0003879_abnormal_hair_cell | 0.66890689 |
| 147 | MP0006035_abnormal_mitochondrial_morpho | 0.66138022 |
| 148 | MP0005023_abnormal_wound_healing | 0.63797425 |
| 149 | MP0003137_abnormal_impulse_conducting | 0.61915803 |
| 150 | MP0000358_abnormal_cell_content/ | 0.59787855 |
| 151 | MP0003690_abnormal_glial_cell | 0.58982479 |
| 152 | MP0004043_abnormal_pH_regulation | 0.58101861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 5.76933929 |
| 2 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.34985577 |
| 3 | Myoglobinuria (HP:0002913) | 4.34858231 |
| 4 | Increased variability in muscle fiber diameter (HP:0003557) | 4.22138855 |
| 5 | EMG: myopathic abnormalities (HP:0003458) | 3.97747316 |
| 6 | Rhabdomyolysis (HP:0003201) | 3.96420733 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.93862954 |
| 8 | Hyperglycinuria (HP:0003108) | 3.78901895 |
| 9 | Hypoglycemic coma (HP:0001325) | 3.61564425 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.43620483 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.42347356 |
| 12 | Increased connective tissue (HP:0009025) | 3.38542592 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 3.35691844 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 3.35536350 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35536350 |
| 16 | Hyperglycinemia (HP:0002154) | 3.32191290 |
| 17 | Exercise-induced myalgia (HP:0003738) | 3.25171380 |
| 18 | Flat cornea (HP:0007720) | 3.08230267 |
| 19 | Hyperammonemia (HP:0001987) | 3.05563594 |
| 20 | Poikilocytosis (HP:0004447) | 3.02331012 |
| 21 | Difficulty running (HP:0009046) | 2.97802833 |
| 22 | Ventricular tachycardia (HP:0004756) | 2.95901023 |
| 23 | Ketosis (HP:0001946) | 2.94999625 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 2.91479712 |
| 25 | Hyperacusis (HP:0010780) | 2.90893469 |
| 26 | Sudden death (HP:0001699) | 2.90617619 |
| 27 | Reticulocytosis (HP:0001923) | 2.88050764 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.87466075 |
| 29 | Deep venous thrombosis (HP:0002625) | 2.86955289 |
| 30 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.80006564 |
| 31 | Nephritis (HP:0000123) | 2.80000909 |
| 32 | Paralysis (HP:0003470) | 2.71243052 |
| 33 | Ketoacidosis (HP:0001993) | 2.70653700 |
| 34 | Xanthomatosis (HP:0000991) | 2.69957240 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.67662562 |
| 36 | Insomnia (HP:0100785) | 2.66439766 |
| 37 | Muscle fiber splitting (HP:0003555) | 2.64523409 |
| 38 | Atrioventricular block (HP:0001678) | 2.64260653 |
| 39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63836996 |
| 40 | Dicarboxylic aciduria (HP:0003215) | 2.63836996 |
| 41 | Bladder diverticulum (HP:0000015) | 2.62776995 |
| 42 | Elfin facies (HP:0004428) | 2.61699613 |
| 43 | Neck muscle weakness (HP:0000467) | 2.56468480 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.55846010 |
| 45 | Difficulty climbing stairs (HP:0003551) | 2.54546898 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.52487322 |
| 47 | Renovascular hypertension (HP:0100817) | 2.51507635 |
| 48 | Ulnar deviation of the wrist (HP:0003049) | 2.50196932 |
| 49 | Abnormality of the calf musculature (HP:0001430) | 2.49987720 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.49738181 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.49738181 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.49738181 |
| 53 | Glomerulonephritis (HP:0000099) | 2.49181341 |
| 54 | Scapular winging (HP:0003691) | 2.49088091 |
| 55 | Polycythemia (HP:0001901) | 2.48987348 |
| 56 | Testicular atrophy (HP:0000029) | 2.48501182 |
| 57 | Myopathic facies (HP:0002058) | 2.48412449 |
| 58 | Cholelithiasis (HP:0001081) | 2.46671747 |
| 59 | Alacrima (HP:0000522) | 2.43602682 |
| 60 | Multiple enchondromatosis (HP:0005701) | 2.42383156 |
| 61 | Hyperglycemia (HP:0003074) | 2.41681335 |
| 62 | Hypoplasia of the iris (HP:0007676) | 2.39287105 |
| 63 | Type 1 muscle fiber predominance (HP:0003803) | 2.38630287 |
| 64 | Distal arthrogryposis (HP:0005684) | 2.38592174 |
| 65 | Neuroendocrine neoplasm (HP:0100634) | 2.38484346 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.37851226 |
| 67 | Hypokinesia (HP:0002375) | 2.37624315 |
| 68 | Spinal rigidity (HP:0003306) | 2.36118721 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.35078853 |
| 70 | Toxemia of pregnancy (HP:0100603) | 2.34196182 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 2.31289346 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 2.29685463 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.28058184 |
| 74 | Nausea (HP:0002018) | 2.26192280 |
| 75 | Vertebral compression fractures (HP:0002953) | 2.24912847 |
| 76 | Generalized amyotrophy (HP:0003700) | 2.24574794 |
| 77 | Calf muscle hypertrophy (HP:0008981) | 2.22615783 |
| 78 | Polar cataract (HP:0010696) | 2.21439314 |
| 79 | Generalized muscle weakness (HP:0003324) | 2.21329695 |
| 80 | Lipoatrophy (HP:0100578) | 2.20432210 |
| 81 | Decreased lacrimation (HP:0000633) | 2.19633905 |
| 82 | Bundle branch block (HP:0011710) | 2.19471127 |
| 83 | Abnormality of the lower motor neuron (HP:0002366) | 2.13757949 |
| 84 | Abnormality of serum amino acid levels (HP:0003112) | 2.13154755 |
| 85 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.13059966 |
| 86 | Subaortic stenosis (HP:0001682) | 2.13059966 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 2.12360540 |
| 88 | Areflexia of lower limbs (HP:0002522) | 2.11474368 |
| 89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11180864 |
| 90 | Albinism (HP:0001022) | 2.09469018 |
| 91 | Acanthocytosis (HP:0001927) | 2.07610872 |
| 92 | Renal duplication (HP:0000075) | 2.07506053 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.07358307 |
| 94 | Hepatocellular carcinoma (HP:0001402) | 2.06925314 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 2.06811538 |
| 96 | Hamartoma of the eye (HP:0010568) | 2.06250881 |
| 97 | Pseudobulbar signs (HP:0002200) | 2.03032772 |
| 98 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.02916640 |
| 99 | Absent phalangeal crease (HP:0006109) | 2.02452006 |
| 100 | Lymphangioma (HP:0100764) | 2.01562116 |
| 101 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.01433736 |
| 102 | Pheochromocytoma (HP:0002666) | 2.00731768 |
| 103 | Hyperlipoproteinemia (HP:0010980) | 2.00351986 |
| 104 | Ankle contracture (HP:0006466) | 2.00202622 |
| 105 | Epidermoid cyst (HP:0200040) | 1.99910532 |
| 106 | Ependymoma (HP:0002888) | 1.99887817 |
| 107 | EMG: neuropathic changes (HP:0003445) | 1.99410404 |
| 108 | Neonatal death (HP:0003811) | 1.99268936 |
| 109 | Spastic diplegia (HP:0001264) | 1.98697672 |
| 110 | Myotonia (HP:0002486) | 1.98378016 |
| 111 | Asymmetric septal hypertrophy (HP:0001670) | 1.98196442 |
| 112 | Cubitus valgus (HP:0002967) | 1.97854957 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 1.97236615 |
| 114 | Heart block (HP:0012722) | 1.96516325 |
| 115 | Hypertriglyceridemia (HP:0002155) | 1.94643214 |
| 116 | Generalized aminoaciduria (HP:0002909) | 1.94223829 |
| 117 | Adenoma sebaceum (HP:0009720) | 1.93640558 |
| 118 | Angiofibromas (HP:0010615) | 1.93640558 |
| 119 | Progressive muscle weakness (HP:0003323) | 1.93420387 |
| 120 | Muscle fiber inclusion bodies (HP:0100299) | 1.93311895 |
| 121 | Nonprogressive disorder (HP:0003680) | 1.93131458 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.93066301 |
| 123 | Bowel diverticulosis (HP:0005222) | 1.92398533 |
| 124 | Back pain (HP:0003418) | 1.91713844 |
| 125 | Dysmetric saccades (HP:0000641) | 1.91471057 |
| 126 | Progressive external ophthalmoplegia (HP:0000590) | 1.91146604 |
| 127 | Conjunctival hamartoma (HP:0100780) | 1.90316729 |
| 128 | Muscle stiffness (HP:0003552) | 1.90257644 |
| 129 | Abnormality of glycolysis (HP:0004366) | 1.89804175 |
| 130 | Abnormality of the 4th metacarpal (HP:0010012) | 1.89456266 |
| 131 | Gout (HP:0001997) | 1.88942061 |
| 132 | Round ear (HP:0100830) | 1.87355630 |
| 133 | Rimmed vacuoles (HP:0003805) | 1.87160839 |
| 134 | Patellar dislocation (HP:0002999) | 1.86622796 |
| 135 | Cardiovascular calcification (HP:0011915) | 1.86574116 |
| 136 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.86258492 |
| 137 | Abnormal atrioventricular conduction (HP:0005150) | 1.86137645 |
| 138 | Prenatal maternal abnormality (HP:0002686) | 1.85610341 |
| 139 | Insulin resistance (HP:0000855) | 1.85552015 |
| 140 | Vascular calcification (HP:0004934) | 1.84490441 |
| 141 | Overriding aorta (HP:0002623) | 1.83534797 |
| 142 | Enlarged penis (HP:0000040) | 1.83005464 |
| 143 | Cerebral hemorrhage (HP:0001342) | 1.82005634 |
| 144 | Hypobetalipoproteinemia (HP:0003563) | 1.81118290 |
| 145 | Abnormality of the salivary glands (HP:0010286) | 1.80694485 |
| 146 | Rectal prolapse (HP:0002035) | 1.79951269 |
| 147 | Hyperkalemia (HP:0002153) | 1.79708380 |
| 148 | Increased serum pyruvate (HP:0003542) | 1.78836760 |
| 149 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.78128129 |
| 150 | Aplasia involving bones of the extremities (HP:0009825) | 1.77579382 |
| 151 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.77579382 |
| 152 | Aplasia of the phalanges of the hand (HP:0009802) | 1.77579382 |
| 153 | Increased nuchal translucency (HP:0010880) | 1.77041441 |
| 154 | Foot dorsiflexor weakness (HP:0009027) | 1.76356657 |
| 155 | Dilated cardiomyopathy (HP:0001644) | 1.75022019 |
| 156 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74330474 |
| 157 | Weak cry (HP:0001612) | 1.73716985 |
| 158 | Abnormality of reticulocytes (HP:0004312) | 1.73226220 |
| 159 | Abnormal cartilage morphology (HP:0002763) | 1.73188063 |
| 160 | Astrocytoma (HP:0009592) | 1.71063153 |
| 161 | Abnormality of the astrocytes (HP:0100707) | 1.71063153 |
| 162 | Hyperbilirubinemia (HP:0002904) | 1.71039606 |
| 163 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.69350271 |
| 164 | Palpitations (HP:0001962) | 1.68665503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.76190841 |
| 2 | PKN2 | 4.11046773 |
| 3 | EEF2K | 3.77282957 |
| 4 | LIMK1 | 3.70530522 |
| 5 | MAP3K10 | 3.09415868 |
| 6 | MOS | 2.81360407 |
| 7 | TTN | 2.61631955 |
| 8 | CDK8 | 2.60155157 |
| 9 | BCKDK | 2.55893848 |
| 10 | EPHA3 | 2.33836257 |
| 11 | NEK1 | 2.33748854 |
| 12 | PDK4 | 2.25383778 |
| 13 | PDK3 | 2.25383778 |
| 14 | LATS1 | 2.10256578 |
| 15 | NEK2 | 2.06509304 |
| 16 | CDC42BPA | 2.03337100 |
| 17 | CLK1 | 2.02357460 |
| 18 | EPHB1 | 2.01571001 |
| 19 | CDK12 | 1.99877920 |
| 20 | SIK1 | 1.80751900 |
| 21 | GRK7 | 1.79558900 |
| 22 | TRPM7 | 1.78980430 |
| 23 | ERN1 | 1.71554904 |
| 24 | CDK4 | 1.54704328 |
| 25 | MAP2K3 | 1.54308108 |
| 26 | CDC7 | 1.53855342 |
| 27 | IRAK3 | 1.51750498 |
| 28 | MAP3K2 | 1.48421400 |
| 29 | FLT3 | 1.45302582 |
| 30 | MST4 | 1.43145633 |
| 31 | NTRK1 | 1.36620996 |
| 32 | MAPKAPK3 | 1.35174396 |
| 33 | ZAP70 | 1.34302464 |
| 34 | CAMK1D | 1.33748849 |
| 35 | LATS2 | 1.31890086 |
| 36 | EIF2AK3 | 1.30294010 |
| 37 | STK3 | 1.29122203 |
| 38 | MTOR | 1.25849800 |
| 39 | EIF2AK1 | 1.25759998 |
| 40 | MET | 1.25087481 |
| 41 | CDK6 | 1.25023820 |
| 42 | FGFR4 | 1.23352678 |
| 43 | MYLK | 1.21434581 |
| 44 | PTK6 | 1.17602596 |
| 45 | TTK | 1.15839882 |
| 46 | LMTK2 | 1.15397916 |
| 47 | STK4 | 1.11131457 |
| 48 | RIPK1 | 1.08964469 |
| 49 | JAK1 | 1.07747025 |
| 50 | PDGFRA | 1.07340483 |
| 51 | KSR1 | 1.07248223 |
| 52 | RPS6KB2 | 1.07173134 |
| 53 | MAP3K7 | 1.05615049 |
| 54 | MAPK11 | 1.05325905 |
| 55 | STK10 | 1.05024020 |
| 56 | OBSCN | 1.03569958 |
| 57 | BUB1 | 1.02845329 |
| 58 | RAF1 | 1.02522406 |
| 59 | MAP3K8 | 1.00850753 |
| 60 | TAOK1 | 0.97186873 |
| 61 | ROCK2 | 0.94358515 |
| 62 | SRPK1 | 0.92596104 |
| 63 | PRKAA1 | 0.92376929 |
| 64 | ABL2 | 0.89717331 |
| 65 | MAP3K1 | 0.89115197 |
| 66 | PHKG1 | 0.88134860 |
| 67 | PHKG2 | 0.88134860 |
| 68 | PIK3CG | 0.88089235 |
| 69 | ICK | 0.87811943 |
| 70 | PDK2 | 0.86309622 |
| 71 | RPS6KA4 | 0.85508637 |
| 72 | BLK | 0.84459341 |
| 73 | PRKAA2 | 0.83297213 |
| 74 | ALK | 0.83037143 |
| 75 | BRSK2 | 0.81668163 |
| 76 | TBK1 | 0.81408520 |
| 77 | NEK9 | 0.78890544 |
| 78 | CAMKK2 | 0.78068526 |
| 79 | STK16 | 0.77850399 |
| 80 | PRPF4B | 0.76747265 |
| 81 | AURKB | 0.73364736 |
| 82 | PLK1 | 0.72941486 |
| 83 | ERBB4 | 0.72408580 |
| 84 | STK38L | 0.72334556 |
| 85 | PRKD3 | 0.71486302 |
| 86 | MAP2K1 | 0.70297525 |
| 87 | LRRK2 | 0.69845789 |
| 88 | AKT2 | 0.68085100 |
| 89 | DMPK | 0.67768374 |
| 90 | DYRK3 | 0.67266805 |
| 91 | ILK | 0.67150916 |
| 92 | SCYL2 | 0.67126018 |
| 93 | STK38 | 0.67050060 |
| 94 | CDK9 | 0.66737328 |
| 95 | RET | 0.66507481 |
| 96 | FGFR1 | 0.66338179 |
| 97 | JAK2 | 0.65299742 |
| 98 | MAP3K3 | 0.64224811 |
| 99 | CAMK1G | 0.63822030 |
| 100 | EIF2AK2 | 0.63014896 |
| 101 | MAP3K12 | 0.62831290 |
| 102 | PDPK1 | 0.61996923 |
| 103 | CDK7 | 0.61656816 |
| 104 | MST1R | 0.60515514 |
| 105 | TESK1 | 0.59856006 |
| 106 | WEE1 | 0.59347211 |
| 107 | ARAF | 0.59142394 |
| 108 | BRSK1 | 0.58756625 |
| 109 | FGFR3 | 0.58484354 |
| 110 | MAP3K5 | 0.57906277 |
| 111 | PRKD2 | 0.57462691 |
| 112 | CHEK1 | 0.57359649 |
| 113 | BMX | 0.55870009 |
| 114 | PASK | 0.55721173 |
| 115 | MAP3K6 | 0.55310699 |
| 116 | PIM1 | 0.54850521 |
| 117 | TIE1 | 0.54709191 |
| 118 | TAOK2 | 0.52305497 |
| 119 | EPHA2 | 0.50749815 |
| 120 | PAK4 | 0.49735033 |
| 121 | STK24 | 0.49311698 |
| 122 | MAP2K4 | 0.49263478 |
| 123 | TGFBR2 | 0.48875881 |
| 124 | CHEK2 | 0.48415205 |
| 125 | MAP4K1 | 0.48135549 |
| 126 | ATR | 0.47605256 |
| 127 | DDR2 | 0.47434276 |
| 128 | SGK3 | 0.46205290 |
| 129 | PDGFRB | 0.46162379 |
| 130 | FER | 0.46008053 |
| 131 | ROCK1 | 0.45495980 |
| 132 | PTK2 | 0.45076891 |
| 133 | MAPKAPK2 | 0.44665489 |
| 134 | RPS6KA1 | 0.44117412 |
| 135 | KDR | 0.43988217 |
| 136 | DYRK1B | 0.42982494 |
| 137 | MAP3K11 | 0.42730653 |
| 138 | CAMK2B | 0.42235169 |
| 139 | PAK2 | 0.42111432 |
| 140 | CDK2 | 0.41936359 |
| 141 | MAPK12 | 0.41175585 |
| 142 | TYK2 | 0.40436307 |
| 143 | ERBB2 | 0.39855886 |
| 144 | YES1 | 0.39025245 |
| 145 | ATM | 0.35947134 |
| 146 | RPS6KA2 | 0.35113128 |
| 147 | MAP3K9 | 0.35071592 |
| 148 | KSR2 | 0.34236674 |
| 149 | MELK | 0.33878928 |
| 150 | MAP2K6 | 0.33464740 |
| 151 | IRAK4 | 0.32319746 |
| 152 | PINK1 | 0.32169704 |
| 153 | PRKD1 | 0.31854989 |
| 154 | AKT3 | 0.30736566 |
| 155 | PAK6 | 0.30477213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.77100150 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.55312706 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.07842521 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.99377293 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.89365026 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.77927563 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.56902900 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55761304 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.48945248 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.13154307 |
| 11 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.11048655 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 2.06624467 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05067248 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84215830 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82334706 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.80906561 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80383870 |
| 18 | Lysine degradation_Homo sapiens_hsa00310 | 1.80260843 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.79097973 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.69340098 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.67177439 |
| 22 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.65903865 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.63694560 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61356950 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59581322 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54065249 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.51784879 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49327338 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42548931 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.41239114 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36909546 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36794834 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35000206 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.33975998 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29068289 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.28112532 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24189747 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22559839 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.21757207 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.18435545 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17863274 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.16250973 |
| 43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12604011 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11989158 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10965815 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.10205799 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.05837161 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.05737967 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04636356 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.04179216 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.04032145 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02484539 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01870069 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01474568 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00857056 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00345824 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99989581 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95875927 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95170383 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92659138 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92330811 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90880036 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.88298781 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88013844 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86213794 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86000270 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83752333 |
| 68 | Melanoma_Homo sapiens_hsa05218 | 0.82911239 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82044678 |
| 70 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.77164956 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77057591 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 0.76665566 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75678116 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.74903622 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74017790 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73970829 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73940955 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.68740439 |
| 79 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67677809 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67657715 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.67438011 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67278581 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65528306 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65494245 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.64425947 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64061902 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59976084 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59314568 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58781692 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.58485906 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57607714 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56846139 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56378260 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55505039 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55382942 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54312737 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54023451 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.53665973 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53472115 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.53448298 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.53312880 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53141751 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52833904 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52153758 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51866636 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51599651 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51598971 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51277167 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51265917 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51211314 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51188746 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50595348 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49826742 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49480598 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49223208 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46928005 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46887642 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46871526 |
| 119 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46158676 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45738296 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44531952 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44311296 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43004180 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42901613 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41351910 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40810435 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.40729608 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39952867 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38243264 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38058368 |
| 131 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36941371 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36253917 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35213040 |
| 134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34351104 |
| 135 | Spliceosome_Homo sapiens_hsa03040 | 0.33939530 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33043997 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32570145 |
| 138 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32157047 |
| 139 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32035501 |

